Any news on when Sarepta is going to start a confirmatory phase III.  All of this waiting around on the FDA to give them their blessing is really dragging me down!  Why not do the confirmatory trial any way if there is such confidence.  My son could surely benefit and I'm sure there are lots of others as well.  So frustrating!!!


Views: 492

Reply to This

Replies to This Discussion

Sarepta may make a statement at next Earnings Conference Call 02/27/14 at 8:00 a.m. ET

Upcoming events for Sarepta


The CEO said on Monday that they will meet with FDA again this month. We can hope...


Urge the FDA to Say YES to Accelerated Approval for safe, effective therapies for children with Duchenne.

We urge the Food and Drug Administration (FDA) to use the Accelerated Approval pathway for approval and access to safe, effective therapies for Duchenne Muscular Dystrophy - the leading genetic killer of children that impacts 1 out of every 3,500 boys born in the United States. It's time for the FDA to Say Yes and make this the first generation of Duchenne survivors.

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service